Entact Bio
PrivateLast Round
Seed Round
Jun 3, 2024
Est. Valuation
$75.9M
Total Funding Raised
$121.3M
Company Overview
Entact Bio operates in Healthcare & Life Sciences and is based in Watertown, Massachusetts. Its latest recorded funding round was a Series A Extension round in January 2024.
Entact Bio is a biotechnology company that develops small-molecule drugs called ENTACs to enhance the function of beneficial proteins through natural cellular mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Entact Bio Comparables
Compare Entact Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stablix | 86% | |
| Vicinitas Therapeutics | 82% | |
| Outrun Therapeutics | 77% |
For institutional investors. Book with your work email.
Entact Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 3, 2024 | ||||
| Series A Extension | Jan 31, 2024 | ||||
| Series A | Dec 6, 2022 | ||||
| Seed | Oct 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Entact Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series A |
| Janus Henderson Group | Series A |
| 4BIO Capital | Series A, Seed |
| Logos Capital | Series A |
| Abingworth | Series A |
| Arkin Holdings | Series A |
| Citadel | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2024
$10M raised in Seed Round.
- Jan 31, 2024
$40.3M round raised
For institutional investors. Book with your work email.
Entact Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Entact Bio's valuation, stock price, and market status.
Is Entact Bio a public or private company?
Entact Bio is a private company.
What is the current stock price of Entact Bio?
Entact Bio is a private company, so its shares have no public market price. Caplight tracks Entact Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Entact Bio worth (valuation)?
Entact Bio's valuation is estimated at $75.9M based on funding round data.
Can I buy Entact Bio stock?
Entact Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Entact Bio's last funding round?
Entact Bio's most recent funding round was Seed Round on June 3, 2024.
Who are the main investors in Entact Bio?
Key investors in Entact Bio include venBio, Qiming.
Will Entact Bio IPO soon?
No public IPO plans have been announced for Entact Bio.
How can I track Entact Bio secondary market activity?
Caplight tracks bids, offers, and trades in Entact Bio's shares on secondary markets.